California Institute of Regenerative Medicine (CIRM)

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 9
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Health Care
  • Genetics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of California Institute of Regenerative Medicine (CIRM):
Typical Co-investors
California Institute of Regenerative Medicine (CIRM) is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after California Institute of Regenerative Medicine (CIRM):
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beyond Impact Minneapolis, Minnesota, United States
Cnpc Capital Beijing, Beijing Shi, China
Coloplast Minneapolis, Minnesota, United States
Comcraft -
Day One Ventures California, San Francisco, United States
Digital Colony Boca Raton, Florida, United States
Encore Consumer Capital California, San Francisco, United States
Guardian Strategic Ventures New York, New York, United States
Hang Lung Group China, Hong Kong, Hong Kong Island
Hickory Group International Richmond, United States, Virginia
Kanematsu Corporation Chiba, Japan, Minato
Macrolink Culturaltainment Development Beijing, China, Tongzhou
Microbiologics Minnesota, Saint Cloud, United States
Nesta Impact Investments England, London, United Kingdom
Principal Capital China, Shanghai
Red Fort Capital -
StartPlanetNI Belfast, Northern Ireland, United Kingdom
Venture Republic Chiyoda, Japan
Xiaoshi Ziben -
Yorkshire Association of Business Angels Harrogate, North Yorkshire, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ray Therapeutics

Biotechnology
Therapeutics
$4M27 Apr 2022 San Diego, California, United States

BioEclipse Therapeutics

Biotechnology
Health Care
Therapeutics
$8M26 Apr 2022 San Francisco, California, United States

Cytonus Therapeutics

Biotechnology
$900K01 Jan 2022 San Diego, California, United States

Rocket Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$3M13 Nov 2020 -

Rocket Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$6M30 Apr 2019 -

AiVita Biomedical

Biotechnology
Manufacturing
Medical
$1M17 Jul 2018 Irvine, California, United States

Poseida Therapeutics

Biotechnology
Genetics
Therapeutics
$4M07 Jul 2018 San Diego, California, United States

Mustang Bio

Biotechnology
Pharmaceutical
$12M11 Oct 2017 New York, New York, United States

SanBio

Agriculture
Biopharma
Biotechnology
Pharmaceutical
$20M05 Jul 2017 Chiyoda, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent California Institute of Regenerative Medicine (CIRM)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: